Moderna shares extend rally after Phase 3 melanoma results
Moderna (MRNA) shares rose 8.18% to $157.53, extending a month-long rally tied to Phase 3 melanoma trial results reported with Merck (MRK).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Treasury buybacks drag yields lower; gold, miners rally
The Treasury’s decision to at least double long-dated debt buybacks pushed benchmark yields lower, weakened the dollar to its lowest since late May and lifted gold-related assets.